Conferences
ASCO GU 2017: Advances in the Understanding and Treatment of Androgen-Receptor-Indifferent Prostate Cancer - Session Highlights
February 16, 2017
ASCO GU 2017: The long tail of significantly mutated genes in prostate cancer - Session Highlights
February 16, 2017
ASCO GU 2017: Genomic Evolution in Primary and Therapy-Resistant Prostate Cancer - Session Highlights
February 16, 2017
ASCO GU 2017: Using Liquid Biopsies to Interrogate Circulating Tumor Clone Dynamics and Prostate - Session Highlights
February 16, 2017
ASCO GU 2017: Prostate cancer meta-analysis from more than 145,000 men to identify 65 novel prostate cancer susceptibility loci - Session Highlights
February 16, 2017
ASCO GU 2017: Active Surveillance Patient Perspective Question and Answer Panel - Session Highlights
February 16, 2017
ASCO GU 2017: Genomic Tests in Active Surveillance and the Role of Hereditary Testing - Session Highlights
February 16, 2017
ASCO GU 2017: Imaging To Guide Active Surveillance - Session Highlights
February 16, 2017
ASCO GU 2017: Canadian Vs. U.S. Guidelines on Active Surveillance - Session Highlights
February 16, 2017
ASCO GU 2017: Welcome Address to the Genitourinary Cancer Symposium 2017 - Session Highlights
February 16, 2017
ASCO GU 2017: Some Patients Experience Long-Term Tumor Control Even After Stopping Immunotherapy Early
February 13, 2017
ASCO GU 2017: Blood Test Uncovers Potential New Treatment Targets in Advanced Prostate Cancer
February 13, 2017
ASCO GU 2017: In Advanced Kidney Cancer, Antibiotic Use Lowers Efficacy of Immunotherapy
February 13, 2017
Role of FSH in the musculoskeletal side effects associated with androgen deprivation therapy (ADT) for prostate cancer
February 7, 2017